[HTML][HTML] Therapeutic strategies for COVID-19: progress and lessons learned

G Li, R Hilgenfeld, R Whitley, E De Clercq - Nature Reviews Drug …, 2023 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …

[HTML][HTML] Structural biology of SARS-CoV-2: open the door for novel therapies

W Yan, Y Zheng, X Zeng, B He, W Cheng - Signal Transduction and …, 2022 - nature.com
Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the causative
agent of the pandemic disease COVID-19, which is so far without efficacious treatment. The …

[HTML][HTML] SARS-CoV-2 virus NSP14 Impairs NRF2/HMOX1 activation by targeting Sirtuin 1

S Zhang, J Wang, L Wang, S Aliyari… - Cellular & molecular …, 2022 - nature.com
Most deaths from the COVID-19 pandemic are due to acute respiratory distress syndrome
(ARDS)-related respiratory failure. Cytokine storms and oxidative stress are the major …

Characterization of SARS2 Nsp15 nuclease activity reveals it's mad about U

MN Frazier, LB Dillard, JM Krahn, L Perera… - Nucleic acids …, 2021 - academic.oup.com
Nsp15 is a uridine specific endoribonuclease that coronaviruses employ to cleave viral RNA
and evade host immune defense systems. Previous structures of Nsp15 from across …

[HTML][HTML] Experimental models of COVID-19

LA Caldera-Crespo, MJ Paidas, S Roy… - Frontiers in cellular …, 2022 - frontiersin.org
COVID-19 is the most consequential pandemic of the 21st century. Since the earliest stage
of the 2019-2020 epidemic, animal models have been useful in understanding the …

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase

J Zeng, F Weissmann, AP Bertolin, V Posse… - Biochemical …, 2021 - portlandpress.com
The coronavirus disease 2019 (COVID-19) pandemic, which is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global public health challenge …

Interfering with nucleotide excision by the coronavirus 3′-to-5′ exoribonuclease

R Chinthapatla, M Sotoudegan… - Nucleic acids …, 2023 - academic.oup.com
Some of the most efficacious antiviral therapeutics are ribonucleos (t) ide analogs. The
presence of a 3′-to-5′ proofreading exoribonuclease (ExoN) in coronaviruses diminishes …

Aurora: a fluorescent deoxyribozyme for high-throughput screening

M Volek, J Kurfürst, M Drexler, M Svoboda… - Nucleic Acids …, 2024 - academic.oup.com
Fluorescence facilitates the detection, visualization, and tracking of molecules with high
sensitivity and specificity. A functional DNA molecule that generates a robust fluorescent …

Comprehensive fragment screening of the SARS‐CoV‐2 proteome explores novel chemical space for drug development

H Berg, MA Wirtz Martin, N Altincekic… - Angewandte Chemie …, 2022 - Wiley Online Library
Abstract SARS‐CoV‐2 (SCoV2) and its variants of concern pose serious challenges to the
public health. The variants increased challenges to vaccines, thus necessitating for …

[HTML][HTML] Discovery of SARS-CoV-2 Nsp14 and Nsp16 methyltransferase inhibitors by high-throughput virtual screening

R Bobrovs, I Kanepe, N Narvaiss, L Patetko, G Kalnins… - Pharmaceuticals, 2021 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses mRNA capping to
evade the human immune system. The cap formation is performed by the SARS-CoV-2 …